Angiogenic circular RNAs: A new landscape in cardiovascular diseases

Microvasc Res. 2020 May:129:103983. doi: 10.1016/j.mvr.2020.103983. Epub 2020 Jan 14.

Abstract

Angiogenesis refers to the formation of new blood vessels from existing blood vessels, including endothelial progenitor cells differentiation and cytokine regulation. Circular RNAs, a type of non-coding RNA, are a stable and conservative endogenous transcriptional product with a circular structure that is produced by the reverse and scrambled splicing of mRNA precursors. They can be used as microRNA sponges, are involved in transcription and protein translation, and regulate the pathophysiological processes of various diseases. Recent studies have shown that circRNAs can regulate angiogenesis by regulating vascular endothelial cell function. In this review, we summarize the angiogenic mechanism; the biogenesis, properties and biological function of circRNAs; and their roles in regulating angiogenesis. We also discuss their potential implications for clinical applications.

Keywords: Angiogenesis; Biomarker; Cardiovascular diseases; Circular RNAs; Endothelial cells; Therapeutic target.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cardiovascular Diseases / genetics
  • Cardiovascular Diseases / metabolism*
  • Cardiovascular Diseases / physiopathology
  • Endothelial Cells / metabolism*
  • Endothelial Progenitor Cells / metabolism
  • Endothelium, Vascular / metabolism*
  • Endothelium, Vascular / physiopathology
  • Gene Expression Regulation
  • Humans
  • Neovascularization, Physiologic* / genetics
  • RNA, Circular / genetics
  • RNA, Circular / metabolism*
  • Signal Transduction

Substances

  • RNA, Circular